FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080249907> ?p ?o ?g. }

• W3080249907 endingPage "153312" @default.
• W3080249907 startingPage "153312" @default.
• W3080249907 abstract "Curcumin functions as a proteasome inhibitor. However, the molecular mechanisms behind this action need more detailed explanations. This study aimed to investigate the inhibitory effect of curcumin on 20S proteasome activity and to elucidate its exact mechanism in triple-negative breast cancer (TNBC) MDA-MB-231 cells. Proteasomal peptidase activities were assayed using synthetic fluorogenic peptide substrates. Knockdown or overexpression of microRNA (miRNA or miR) or protein was used to investigate its functional effect on downstream cellular processes. BrdU (5‑bromo‑2′-deoxyuridine) assay was performed to identify cell proliferation. Western blot and quantitative real-time PCR(qRT-PCR) were carried out to determine protein abundance and miRNA expression, respectively. Correlations between protein expressions, miRNA levels, and proteasome activities were analyzed in TNBC tissues. Xenograft tumor model was performed to observe the in vivo effect of curcumin on 20S proteasome activity. Curcumin significantly reduced PSMB5 protein levels, accompanied with a reduction in the chymotrypsin-like (CT-l) activity of proteasome 20S core. Loss of PSMB5 markedly inhibited the CT-l activity of 20S proteasome. Furthermore, curcumin treatment significantly elevated miR-142–3p expression. PSMB5 was a direct target of miR-142–3p and its protein levels were negatively regulated by miR-142–3p. Moreover, histone acetyltransferase p300 suppressed miR-142–3p expression. Overexpression of p300 mitigated the promotive effect of curcumin on miR-142–3p expression. The correlations among p300 abundances, miR-142–3p levels, PSMB5 expressions, and the CT-l activities of 20S proteasome were evidenced in TNBC tissues. In addition, loss of p300 and PSMB5 reduced cell proliferation. Inhibition of miR-142–3p significantly attenuated the inhibitory impact of curcumin on cell proliferation. These curcumin-induced changes on p300, miR-142–3p, PSMB5, and 20S proteasome activity were further confirmed in in vivo solid tumor model. These findings demonstrated that curcumin suppressed p300/miR-142–3p/PSMB5 axis leading to the inhibition of the CT-l activity of 20S proteasome. These results provide a novel and alternative explanation for the inhibitory effect of curcumin on proteasome activity and also raised potential therapeutic targets for TNBC treatment." @default.
• W3080249907 created "2020-09-01" @default.
• W3080249907 creator A5002695529 @default.
• W3080249907 creator A5016809518 @default.
• W3080249907 creator A5041072835 @default.
• W3080249907 creator A5043161993 @default.
• W3080249907 creator A5059788283 @default.
• W3080249907 date "2020-11-01" @default.
• W3080249907 modified "2023-09-30" @default.
• W3080249907 title "Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142–3p/PSMB5 axis" @default.
• W3080249907 cites W1844216079 @default.
• W3080249907 cites W1988492454 @default.
• W3080249907 cites W1989703280 @default.
• W3080249907 cites W2024097609 @default.
• W3080249907 cites W2038248439 @default.
• W3080249907 cites W2043943641 @default.
• W3080249907 cites W2052296178 @default.
• W3080249907 cites W2068380884 @default.
• W3080249907 cites W2069470172 @default.
• W3080249907 cites W2106359723 @default.
• W3080249907 cites W2123752216 @default.
• W3080249907 cites W2132329932 @default.
• W3080249907 cites W2132967023 @default.
• W3080249907 cites W2146533274 @default.
• W3080249907 cites W2148947476 @default.
• W3080249907 cites W2161701924 @default.
• W3080249907 cites W2335231316 @default.
• W3080249907 cites W2553564883 @default.
• W3080249907 cites W2593698871 @default.
• W3080249907 cites W2625495108 @default.
• W3080249907 cites W2732040307 @default.
• W3080249907 cites W2798011605 @default.
• W3080249907 cites W2811476529 @default.
• W3080249907 cites W2861982167 @default.
• W3080249907 cites W2885938058 @default.
• W3080249907 cites W2887453177 @default.
• W3080249907 cites W2892868770 @default.
• W3080249907 cites W2901917768 @default.
• W3080249907 cites W2902116368 @default.
• W3080249907 cites W2914775587 @default.
• W3080249907 cites W2978605903 @default.
• W3080249907 cites W2997513201 @default.
• W3080249907 cites W3012866857 @default.
• W3080249907 doi "https://doi.org/10.1016/j.phymed.2020.153312" @default.
• W3080249907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32866906" @default.
• W3080249907 hasPublicationYear "2020" @default.
• W3080249907 type Work @default.
• W3080249907 sameAs 3080249907 @default.
• W3080249907 citedByCount "28" @default.
• W3080249907 countsByYear W30802499072021 @default.
• W3080249907 countsByYear W30802499072022 @default.
• W3080249907 countsByYear W30802499072023 @default.
• W3080249907 crossrefType "journal-article" @default.
• W3080249907 hasAuthorship W3080249907A5002695529 @default.
• W3080249907 hasAuthorship W3080249907A5016809518 @default.
• W3080249907 hasAuthorship W3080249907A5041072835 @default.
• W3080249907 hasAuthorship W3080249907A5043161993 @default.
• W3080249907 hasAuthorship W3080249907A5059788283 @default.
• W3080249907 hasConcept C104317684 @default.
• W3080249907 hasConcept C121608353 @default.
• W3080249907 hasConcept C145059251 @default.
• W3080249907 hasConcept C153911025 @default.
• W3080249907 hasConcept C173396325 @default.
• W3080249907 hasConcept C185592680 @default.
• W3080249907 hasConcept C190283241 @default.
• W3080249907 hasConcept C27740335 @default.
• W3080249907 hasConcept C2776415932 @default.
• W3080249907 hasConcept C2778250585 @default.
• W3080249907 hasConcept C2778367456 @default.
• W3080249907 hasConcept C2780110267 @default.
• W3080249907 hasConcept C502942594 @default.
• W3080249907 hasConcept C530470458 @default.
• W3080249907 hasConcept C54355233 @default.
• W3080249907 hasConcept C55493867 @default.
• W3080249907 hasConcept C86803240 @default.
• W3080249907 hasConcept C95444343 @default.
• W3080249907 hasConceptScore W3080249907C104317684 @default.
• W3080249907 hasConceptScore W3080249907C121608353 @default.
• W3080249907 hasConceptScore W3080249907C145059251 @default.
• W3080249907 hasConceptScore W3080249907C153911025 @default.
• W3080249907 hasConceptScore W3080249907C173396325 @default.
• W3080249907 hasConceptScore W3080249907C185592680 @default.
• W3080249907 hasConceptScore W3080249907C190283241 @default.
• W3080249907 hasConceptScore W3080249907C27740335 @default.
• W3080249907 hasConceptScore W3080249907C2776415932 @default.
• W3080249907 hasConceptScore W3080249907C2778250585 @default.
• W3080249907 hasConceptScore W3080249907C2778367456 @default.
• W3080249907 hasConceptScore W3080249907C2780110267 @default.
• W3080249907 hasConceptScore W3080249907C502942594 @default.
• W3080249907 hasConceptScore W3080249907C530470458 @default.
• W3080249907 hasConceptScore W3080249907C54355233 @default.
• W3080249907 hasConceptScore W3080249907C55493867 @default.
• W3080249907 hasConceptScore W3080249907C86803240 @default.
• W3080249907 hasConceptScore W3080249907C95444343 @default.
• W3080249907 hasFunder F4320321001 @default.
• W3080249907 hasLocation W30802499071 @default.
• W3080249907 hasLocation W30802499072 @default.
• W3080249907 hasOpenAccess W3080249907 @default.

• next